Ironwood Pharmaceuticals, Inc. (IRWD)
3.04
-0.19
(-5.88%)
USD |
NASDAQ |
Mar 20, 16:00
3.24
+0.20
(+6.58%)
After-Hours: 20:00
Ironwood Pharmaceuticals EPS Diluted (Quarterly) : -0.014 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AbbVie, Inc. | 1.018 |
| Outlook Therapeutics, Inc. | -0.383 |
| Nektar Therapeutics | -1.778 |
| Rigel Pharmaceuticals, Inc. | 13.54 |
| Recursion Pharmaceuticals, Inc. | -0.2053 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.276M |
| Revenue (Quarterly) | 47.71M |
| Total Expenses (Quarterly) | 49.98M |
| Enterprise Value | 878.04M |
| Gross Profit Margin (Quarterly) | 99.04% |
| Profit Margin (Quarterly) | -4.77% |
| Earnings Yield | 3.97% |
| Operating Earnings Yield | 23.05% |
| Normalized Earnings Yield | 6.836 |